Evaluation of the Protective Effects of Arbutin Via Hormonal, Anti-Inflammatory, and Antioxidant Pathways in Experimental Sepsis Induced Ovarian Damage
Abstract
The present study evaluated the dose-dependent protective effects of arbutin against sepsis-induced ovarian damage and to compare its prophylactic and post-sepsis adjuvant administration in rats. Forty-nine female Wistar albino rats were randomly assigned to seven groups (n=7): Control, Sham, pre-sepsis arbutin 50 mg/kg (Pre50), pre-sepsis arbutin 100 mg/kg (Pre100), Sepsis (SPS), post-sepsis arbutin 50 mg/kg (Post50), and post-sepsis arbutin 100 mg/kg (Post100). Sepsis was induced via cecal puncture. All sepsis groups received intramuscular amikacin (20 mg/kg/day) for five consecutive days. Arbutin was administered orally for seven days prior to sepsis (prophylactic protocol) or concurrently with antibiotics (post-sepsis protocol). Serum anti-Müllerian hormone (AMH) and estradiol (E2) levels were measured, and ovarian tissue concentrations of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), malondialdehyde (MDA), and glutathione (GSH) were determined. Sepsis significantly decreased serum AMH, E2, and ovarian GSH levels, while markedly increasing TNF-α, IL-6, and MDA concentrations. In arbutin-treated groups, both prophylactic and post-sepsis administration increased GSH and reduced TNF-α, IL-6, and MDA levels compared with the sepsis group. Although hormonal parameters improved partially, AMH and E2 did not return to control values within the experimental period. Protective effects were similar across both doses 50 and 100 mg/kg, suggesting a dose-independent response. In conclusion, arbutin alleviated sepsis-induced inflammatory and oxidative ovarian damage through antioxidant and anti-inflammatory mechanisms; however, complete endocrine recovery was not achieved.
Keywords
Supporting Institution
Project Number
Ethical Statement
Thanks
References
- Bian, X. X., Zhao, X., Ma, C. H., & Shen, C. P. (2022). Arbutin alleviates LPS induced sepsis pneumonia in mice. Evidence‐Based Complementary and Alternative Medicine, 2022(1), 5863952.
- Birdal, O., Ferah Okkay, I., Okkay, U., Bayram, C., Mokthare, B., Ertugrul, M. S.,…Saygi, M. (2024). Protective effects of arbutin against doxorubicin-induced cardiac damage. Molecular Biology Reports, 51(1), 532.
- Cai, L., Rodgers, E., Schoenmann, N., & Raju, R. P. (2023). Advances in rodent experimental models of sepsis. International journal of molecular sciences, 24(11), 9578.
- Demir, E. A., Mentese, A., Yilmaz, Z. S., Alemdar, N. T., Demir, S., & Aliyazicioglu, Y. (2023). Evaluation of the therapeutic effects of arbutin on cisplatin‐induced ovarian toxicity in rats through endoplasmic reticulum stress and Nrf2 pathway. Reproductive Biology, 23(4), 100824.
- Ebrahim-Tabar, F., Nazari, A., Pouramir, M., Ashrafpour, M., & Pourabdolhossein, F. (2020). Arbutin improves functional recovery and attenuates glial activation in lysolecethin-induced demyelination model in rat optic chiasm. Molecular Neurobiology, 57(7), 3228- 3242.
- Gökçek, İ., & Uyanık, G. (2025). Protective Effects of Thymol with Hormonal, Antiinflammatory and Antioxidant Pathways in Lipopolysaccharide-Induced Ovarian Damage in Rats. Veterinary Sciences and Practices, 20(1), 1-7.
- Gökçek, İ., Uyanık, G., Tutar, T., & Gözer, A. (2025). Effects of carvacrol on hormonal, inflammatory, antioxidant changes, and ovarian reserve in polycystic ovary syndrome in Wistar rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(4), 4607-4616.
- Guan, H. Y., Xia, H.X., Chen, X.Y., Wang, L., Tang, Z.J., & Zhang, W. (2021). Toll-like receptor 4 inhibits estradiol secretion via NF-κB signaling in human granulosa cells. Frontiers in Endocrinology, 12, 629554.
Details
Primary Language
English
Subjects
Veterinary Obstetrics and Gynecology
Journal Section
Research Article
Authors
Gökhan Uyanık
*
0000-0003-4488-3055
Türkiye
İshak Gökçek
0000-0002-0590-6405
Türkiye
Murat Abay
0000-0003-2457-1919
Türkiye
Publication Date
June 26, 2026
Submission Date
March 4, 2026
Acceptance Date
April 2, 2026
Published in Issue
Year 2026 Volume: 15 Number: 2
